Sun Pharma up nearly 2% post-March quarter nos; here's what brokerages say

Net profit, too, saw a 37 per cent YoY fall to Rs 399.8 crore, against estimates of Rs 950-1,000 crore.

Shares of pharma major, Sun Pharma, oscillated between the positive and negative zones in the morning session on Thursday after the company reported a 17 per cent year-on-year (YoY) decline in its consolidated profit before tax (PBT) at Rs 577 crore for the March quarter.

At 10:14 am, the stock was trading nearly 2 per cent higher at Rs 458.70 apiece on the BSE. In comparison, the benchmark S&P BSE Sensex was ruling over a per cent higher at 31,967.21 levels.  In the early trade, the stock had slipped over 1 per cent to Rs 444.75 against Wednesday's close of Rs 450.55. 

Sun